Imaging chronic daily headache

Current Pain and Headache Reports

Volumn 7, Issue 3, 2003, Pages 209-211

  Aurora, Sheena K ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROERGOTAMINE; ERGOTAMINE; PARACETAMOL; TARTARIC ACID;

BRAIN STEM; CHRONIC DISEASE; DIAGNOSTIC IMAGING; HEADACHE; HUMAN; MEDICAL LITERATURE; MIGRAINE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NOCICEPTION; REVIEW; HEADACHE AND FACIAL PAIN;

DIAGNOSTIC IMAGING; HEADACHE DISORDERS; HUMANS;

EID: 0037492251     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0074-5     Document Type: Review

References (24)

1. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1-96.
2. Silberstein SD, Lipton R, Solomon S, Mathew N: Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994, 34:1-7.
3. Sjaastad O, Spierings EL: Hemincraia continua: another headache absolutely responsive to indomethicin. Cephalalgia 1984, 4:65-70.
4. Diaz-Mitoma F, Vanast WJ, Tyrrell DL: Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987, 1:411-415.
5. Mathew NT, Stubits E, Nigam M: Transformation of migraine into daily headache: analysis of factors. Headache 1982, 22:66-68.
6. Wang HZ, Simonson TM, Greco WR, Yuh WTC: Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Acad Radiol 2001, 8:405-408.
7. Weingarten S, Kleinman M, Elperin L, Larson EB: The effectiveness of cerebral imaging in the diagnosis of chronic headache. Arch Intern Med 1992, 152:2457-2462.
8. Raskin NH, Hosobuchi Y, Lamb S: Headache may arise from perturbation of brain. Headache 1987, 27:416-420.
9. Weiller C, May A, Limmroth V, et al.: Brainstem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658-660.
10. Knight YE, Goadsby PJ: The periaqueductal gray matter modulates trigeminovascular input: a role in migraine. Neuroscience 2001, 106:793-800.
11. Haas DC, Kent PF, Friedman DI: Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993, 33:452-455.
12. Goadsby PJ: Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 2002, 22:107-111.
13. Mathew NT, Kailasam J Meadors L: Cavernous angiomas in the "brain stem generator" areas but not in other brain sites causing chronic migraine in subjects with familial cavernous angiomas. Headache 2002, 42:447-448.
14. Welch KMA, Cao Y, Aurora SK, et al.: MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465-1469.
15. Cao Y, Aurora SK, Vikingstad EM, et al.: Functional MRI of the red nucleus and occipital cortex during visual stimulation of subjects with migraine. Neurology 2002, 59:72-78.
16. Iadarola MJ, Berman KF, Zeffiro TA, et al.: Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain 1998, 121:931-947.
17. Morris CM, Candy JM, Omar S, et al.: Transferrin receptors in the parkinsonian midbrain. Neuropathol Appl Neurobiol 1994, 20:468-472.
18. Gelman N, Gorell JM, Barker PB, et al.: MR Imaging of human brain at 3.0 T: preliminary report of transverse relaxation rates and relation to estimated iron content. Radiology 1999, 210:759-767.
19. Welch KMA, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness. Headache 2001, 41:629-637.
20. Kruit MC, van Buchem MA, Overbosch J, et al.: Iron deposits in migraine: red nucleus and putamen involved? A population based case-control MR imaging study, the camera-project. Cephalalgia 2002, 22:571.
21. Aurora SK, Nagesh V, Norris L, Welch KMA: Functional imaging of subcortical nociceptive structures in response to treatment of chronic daily headache. Cephalalgia 2002, 22:570.
22. Smith GS, Savery D, Marden C, et al.: Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal gray in the rat.1: J Comp Neurol 1994, 350:23-40.
23. Criswell HE: Analgesia and hyperactivity following morphine microinjection into mouse brain. Pharmacol Biochem Behav 1976, 4:23-26.
24. Christie MJ, Williams JT, Osborne PB, Bellchambers CE: Where is the locus in opioid withdrawal? Trends Pharmacol Sci 1997, 18:134-140.